SEC Form 4 · accession 0001209191-15-060426
Foundation Medicine, Inc. · FMI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert W. Hesslein
Officer — SVP and General Counsel
Period of report
Jul 8, 2015
Accepted (ET)
Jul 10, 2015 · 4:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001488613
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 8, 2015 | M | 3,124 | $4.16 | A | 35,349 | D | |
| Common Stock | Jul 8, 2015 | M | 1,563 | $7.12 | A | 36,912 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $4.16 | Jul 8, 2015 | M | 3,124 | D | — | Mar 7, 2023 | common stock | 3,124 | 10,942 | D |
| Stock Option (right to buy)F2 | $7.12 | Jul 8, 2015 | M | 1,563 | D | — | May 21, 2023 | common stock | 1,563 | 7,812 | D |
Explanation of responses
- F1This option was granted on March 7, 2013 and vests in equal quarterly installments over a four-year period beginning on June 7, 2013.
- F2This option was granted on May 21, 2013 and vests in equal quarterly installments over a four-year period beginning on April 1, 2014.